TipRanks
Go Ultimate55% OFF

Insight Molecular Diagnostics (IMDX) Balance Sheet

Insight Molecular Diagnostics Balance Sheet

Insight Molecular Diagnostics's total assets for Q2 2026 were $29.44M, a decrease of 27.17% from the previous quarter. IMDX total liabilities were $50.74M for the fiscal quarter, a 0.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Mar 24Mar 23Dec 21
$ 25.76M$ 35.08M$ 74.89M$ 100.09M$ 159.56M
$ 57.22M$ 47.35M$ 54.42M$ 60.50M$ 94.35M
$ -31.46M$ -12.27M$ 20.47M$ 39.59M$ 65.22M

Currency in USD

Insight Molecular Diagnostics Debt to Assets

060M120M180M0 %80 %160 %240 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets